✦ LIBER ✦

O-188 Phase II study of the EGFR tyrosine kinase inhibitor erlotinib (Tarceva) in patients >70 years of age with previously untreated advanced non-small cell lung carcinoma

✍ Scribed by Jackman, D.; Lucca, J.; Fidias, P.; Rabin, M.; Lynch, T.; Ostler, P.; Skarin, A.; Temel, J.; Johnson, B.; Janne, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1127 POSTER Phase II study of the EGFR t

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Erratum to: Sunitinib malate in previous

✍ Craig Reynolds, Alexander I. Spira, Larry Gluck, Suzanne J. Bradie-Muller, Feng 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 58 KB

Open, randomized, multi-center phase II

✍ Heigener, D.F.; Deppermann, K.M.; Pawel, J.v.; Fischer, J.R.; Kortsik, C.; Bohne 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 518 KB

Weekly Paclitaxel in Elderly Patients (A

✍ David Rossi; Donatella Dennetta; Marcello Ugolini; Paolo Alessandroni; Vincenzo 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 115 KB

A phase I and pharmacokinetic study of d

✍ Glenwood Goss; Frances A. Shepherd; Scott Laurie; Isabelle Gauthier; N. Leighl; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 137 KB